Clipping of news on Brazilian Culture, Law and Citizenship
06/09/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Individual plans would offer medicines for diseases such as diabetes, asthma, COPD, hypertension and heart failure and coronary insufficiencies
The National Health Agency (ANS) on Wednesday announced the opening of a public consultation on proposals to receive as it will encourage health plans to provide medicines for patients with chronic diseases. By law, the agency can not require drug plans to offer household. As should favor the treatment of conditions which afflict more, such as diabetes, bronchial asthma, and hypertension, and to prevent aggravation caused by lack of medicines or by stopping the medication. Carriers can pass the costs for tuition.
Apart from providing medicines, the agency wants to create mechanism for monitoring the patient after hospitalization or complication. "You have to make the person take the medication correctly.'s An extremely effective way to reduce complications and to have longer life and better health," says Martha Oliveira, General Manager of Regulatory Assistance ANS.
The individual plans would have to offer at least six drugs for diseases: diabetes, asthma, chronic obstructive pulmonary disease (COPD), hypertension, coronary artery disease and congestive heart failure. As for plans to free collective bargaining valley. For 30 days, from September 4 to October 3, the agency receives suggestions for public consultation. To participate, simply access the site of ANS (www. ans.gov.br) in "Society Participation / Public Consultation".
Cancer - The proposed SLA does not cover domiciliary chemotherapy. The mandatory provision of this type of medicine is already being addressed in the bill, which before Congress. "The ANS totally agree with the logic of oral medication for cancer be provided by the health plan. Medication for cancer chemotherapy has evolved and no longer has to be either venous," says Martha. The provision of oral chemotherapy has been conquered by the plans in court.
Plans - The National Federation of Health Insurance, which represents 15 business groups, accounting for 36.6% of the beneficiaries, recalled in a statement that "the offer and formatting of this product is a commercial decision and strategy of each company." "International experiences, according to analysis by the Institute for Health Insurance (IESS) based on scientific papers published in journals in the U.S., pointing upward trend in expenditure on medicines. Especially because these studies are inconclusive as to the benefits on health of contracting health plans, "says a statement.
Source: See On Line
Our news are removed entirely from the sites of our partners. For this reason, we can not change their content even in cases of typos.
This article was translated by an automatic translation system, and was therefore not reviewed by people.